Various probiotic strains also show benefits in reducing body fat, improving lipid profiles, and enhancing insulin sensitivity, indicating that targeted probiotic therapies could be developed for metabolic conditions such as obesity and diabetes, providing a novel approach to metabolic health management [92,93,94]. Here, INS is linked to diabetes mellitus.